YOR376W Antibody

What is YOR376W and why is it significant in yeast research?

YOR376W is a gene located on the right arm of chromosome XV in Saccharomyces cerevisiae (UniProt accession Q08900), encoding a protein that is studied in Baker's yeast (strain ATCC 204508/S288c) . The significance of this gene lies in its role in yeast cellular processes, making its antibody an important tool for researchers investigating yeast protein expression, localization, and function. Like many antibodies used in biomedical research, YOR376W antibodies allow researchers to detect, quantify, localize, and potentially perturb the function of their target protein even within complex protein mixtures such as cell lysates . The study of yeast proteins through antibody-based methods contributes to our understanding of fundamental cellular mechanisms that may have parallels in human biology.

How can I verify the specificity of a commercial YOR376W antibody?

Verifying antibody specificity is critical given that approximately 50% of commercial antibodies fail to meet basic standards for characterization, resulting in significant financial and research reliability losses . For YOR376W antibody, a comprehensive validation approach should include:

• Knockout (KO) control experiments: Using Saccharomyces cerevisiae strains with YOR376W gene deletion as negative controls in Western blots, immunoprecipitation, and immunofluorescence assays. This approach has been demonstrated to be superior to other types of controls, particularly for immunofluorescence imaging .

• Recombinant protein controls: Testing the antibody against purified recombinant YOR376W protein.

• Cross-reactivity testing: Evaluating potential cross-reactivity with other yeast proteins, especially those with sequence similarity.

• Application-specific validation: Confirming the antibody performs as expected in your specific experimental conditions and assays (Western blot, immunoprecipitation, etc.) .

• Consulting antibody repositories: Checking repositories like YCharOS (zenodo.org/communities/ycharos) for independent validation data on your antibody .

Remember that antibody validation is application-specific - an antibody that works well in Western blot may not perform adequately in immunofluorescence.

What antibody databases or search engines can help me find validated YOR376W antibodies?

When searching for validated YOR376W antibodies, several specialized search engines and repositories can be valuable resources:

For YOR376W specifically, as it is a yeast protein, you may need to use general antibody search engines rather than human-focused resources like the Human Protein Atlas. CiteAb and Antibody Resource search engines offer the advantage of searching across multiple vendors simultaneously, potentially including validation data . Always cross-reference vendor claims with independent validation data when available, as a shocking 12 publications per protein target (on average) include data from antibodies that failed to recognize their target proteins .

How can I optimize Western blot conditions specifically for YOR376W antibody detection in yeast lysates?

Optimizing Western blot conditions for YOR376W antibody requires careful consideration of yeast-specific factors and general antibody principles:

• Sample preparation optimization:

  • Use the appropriate lysis buffer for yeast cells, typically containing glass beads and protease inhibitors

  • Consider testing both native and denaturing conditions, as the YOR376W epitope accessibility may differ

  • Optimize protein loading (10-50 μg total protein) to balance signal strength and specificity

• Blocking optimization:

  • Test different blocking agents (5% BSA vs. 5% non-fat dry milk) to minimize background

  • For phospho-specific detection, BSA is preferred as milk contains phosphoproteins

• Antibody dilution optimization:

  • Perform a titration experiment (e.g., 1:500, 1:1000, 1:2000, 1:5000)

  • Consider extended low-temperature incubation (4°C overnight) versus shorter room temperature incubation

  • Follow the consensus protocols developed by YCharOS for standardized Western blot methods

• Controls:

  • Include YOR376W knockout yeast strain as a negative control

  • Consider using tagged recombinant YOR376W as a positive control

  • Test with a secondary antibody-only control to evaluate background

• Detection optimization:

  • Compare chemiluminescence, fluorescence, and colorimetric detection methods

  • For quantitative analysis, fluorescence-based detection offers superior linearity

YCharOS studies have demonstrated that the use of knockout cell lines is superior to other types of controls for Western blots, which is particularly relevant for yeast protein detection where genetic manipulation is straightforward .

What are the considerations for using YOR376W antibody in co-immunoprecipitation to study protein-protein interactions?

Co-immunoprecipitation (Co-IP) with YOR376W antibody requires careful experimental design to preserve protein-protein interactions while achieving specific immunoprecipitation:

• Lysis conditions:

  • Use gentle, non-denaturing lysis buffers (e.g., RIPA or NP-40 based)

  • Optimize salt concentration (typically 100-150 mM NaCl) to balance interaction preservation with non-specific binding reduction

  • Include protease and phosphatase inhibitors to maintain protein integrity

• Antibody selection considerations:

  • Evaluate if the epitope recognized by the antibody is accessible in native protein complexes

  • Consider using multiple antibodies targeting different epitopes of YOR376W

  • Test a pre-clearing step with non-specific IgG to reduce background

• Binding conditions:

  • Optimize antibody amount (typically 1-5 μg per mg of protein lysate)

  • Determine optimal binding time (4-16 hours) and temperature (4°C is standard)

  • Consider cross-linking the antibody to beads to avoid antibody contamination in the eluted samples

• Controls:

  • Include IgG isotype control immunoprecipitation

  • Use YOR376W knockout strain lysate as a negative control

  • Consider reversed Co-IP with antibodies against suspected interaction partners

• Detection strategy:

  • Use highly specific secondary antibodies for Western blot detection

  • Consider mass spectrometry for unbiased identification of interaction partners

  • Validate novel interactions with alternative methods (e.g., yeast two-hybrid)

For a standardized approach, follow consensus protocols developed through industry-academic collaborations, such as those from YCharOS, which have established optimized conditions for immunoprecipitation assays .

How can I determine the cross-reactivity profile of YOR376W antibody with homologous proteins in other yeast species?

Determining cross-reactivity with homologous proteins requires systematic testing against multiple species and careful experimental design:

• Sequence analysis:

  • Perform sequence alignment of YOR376W with homologous proteins in other yeast species

  • Identify conservation within the epitope region (if known) to predict potential cross-reactivity

  • Generate phylogenetic trees to visualize evolutionary relationships

• Experimental validation approach:

  • Test against lysates from multiple yeast species (S. cerevisiae, S. pombe, C. albicans, etc.)

  • Include wild-type and YOR376W homologue knockout controls for each species

  • Use recombinant proteins of the homologues for direct binding assessment

• Analytical techniques:

  • Western blotting with standardized protein loading across species

  • Immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Epitope mapping to determine the specific binding region of the antibody

• Quantitative assessment:

  • Calculate relative binding affinities to homologues using surface plasmon resonance or bio-layer interferometry

  • Determine EC50 values for each potential cross-reactive protein

  • Compare signal intensities in Western blots with standardized protein amounts

• Documentation and reporting:

  • Document all cross-reactivity in a standardized format

  • Distinguish between significant cross-reactivity and background signal

  • Share data in antibody repositories to benefit the research community

Recent antibody characterization efforts have revealed that recombinant antibodies generally outperform both monoclonal and polyclonal antibodies in specificity tests, which should be considered if cross-reactivity is a significant concern in your experimental system .

What controls are essential when using YOR376W antibody in immunofluorescence microscopy of yeast cells?

Immunofluorescence microscopy with YOR376W antibody requires rigorous controls to ensure valid localization data:

• Genetic controls:

  • YOR376W knockout strain (essential negative control)

  • YOR376W-tagged strain (GFP or other fluorescent protein) as localization reference

  • Overexpression strain to confirm signal increases with protein levels

• Technical controls:

  • Secondary antibody-only control to assess background fluorescence

  • Isotype control antibody to evaluate non-specific binding

  • Peptide competition assay where pre-incubation with the immunizing peptide should abolish specific staining

  • Autofluorescence control (untreated cells)

• Fixation method controls:

  • Compare multiple fixation methods (paraformaldehyde, methanol, etc.)

  • Evaluate epitope accessibility under different permeabilization conditions

  • Consider native versus denatured protein detection requirements

• Imaging controls:

  • Include z-stack acquisition to confirm complete cellular distribution

  • Use spectral unmixing for multi-color imaging to eliminate bleed-through

  • Implement consistent exposure settings between samples and controls

• Colocalization controls:

  • Include markers for subcellular compartments to verify localization

  • Calculate colocalization coefficients quantitatively

  • Use super-resolution techniques for precise localization claims

Research from YCharOS has demonstrated that knockout controls are even more critical for immunofluorescence than for Western blots, highlighting the importance of genetic controls when making localization claims . The use of standardized protocols, such as those developed through industry-academic collaborations, can help ensure reproducibility across laboratories.

How should I quantify YOR376W protein expression using antibody-based methods?

Quantifying YOR376W protein expression requires careful consideration of methodological approaches and appropriate controls:

• Western blot quantification:

  • Use fluorescent secondary antibodies rather than chemiluminescence for better linearity

  • Include a standard curve of recombinant YOR376W protein

  • Normalize to multiple loading controls (e.g., actin, GAPDH, total protein stain)

  • Use image analysis software with background subtraction

  • Report relative fold changes rather than absolute values unless using a standard curve

• Flow cytometry quantification:

  • Establish a staining protocol with appropriate permeabilization for intracellular antigens

  • Use mean fluorescence intensity (MFI) for quantification

  • Include quantification beads as standards

  • Compare with isotype control and YOR376W knockout cells

  • Consider dual staining with a YOR376W-GFP fusion for validation

• ELISA-based quantification:

  • Develop a sandwich ELISA with two antibodies recognizing different epitopes

  • Generate a standard curve with purified recombinant protein

  • Validate linearity within the expected concentration range

  • Test for matrix effects from yeast lysates

  • Include spike recovery experiments to confirm accuracy

• Mass spectrometry-based validation:

  • Use targeted mass spectrometry as an antibody-independent validation

  • Implement selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

  • Include isotope-labeled reference peptides for absolute quantification

  • Compare results with antibody-based methods to identify potential biases

For any quantification method, standardized protocols similar to those developed by industry-academic collaborations like YCharOS should be followed to ensure reproducibility . The choice between relative and absolute quantification should be based on experimental requirements and available standards.

What are the considerations for using YOR376W antibody in chromatin immunoprecipitation (ChIP) experiments?

Using YOR376W antibody in ChIP experiments requires special considerations for studying DNA-protein interactions:

• Antibody evaluation for ChIP:

  • Test antibody recognition of cross-linked YOR376W protein

  • Evaluate if the epitope remains accessible after formaldehyde treatment

  • Consider using multiple antibodies against different epitopes

  • Validate with tagged YOR376W strains (e.g., FLAG-YOR376W)

• Cross-linking optimization:

  • Test multiple formaldehyde concentrations (typically 0.75-3%)

  • Optimize cross-linking time (5-30 minutes)

  • Consider dual cross-linking with additional agents for improved protein-protein fixation

  • Evaluate cross-linking reversal efficiency with your extraction method

• Sonication/fragmentation parameters:

  • Optimize sonication conditions for yeast cells (power, cycle, duration)

  • Aim for chromatin fragments of 200-500 bp

  • Verify fragmentation by agarose gel electrophoresis

  • Consider enzymatic fragmentation alternatives

• Immunoprecipitation conditions:

  • Determine optimal antibody concentration through titration

  • Evaluate pre-clearing steps to reduce background

  • Optimize wash stringency to balance specificity and sensitivity

  • Include appropriate blocking agents to minimize non-specific binding

• Controls:

  • Input chromatin (pre-immunoprecipitation) control

  • Non-specific IgG control

  • YOR376W knockout strain as negative control

  • Positive controls: known binding sites or tagged protein ChIP

  • Non-binding region controls for qPCR analysis

• Analysis approaches:

  • qPCR for known targets

  • ChIP-seq for genome-wide binding profile

  • Include spike-in controls for quantitative comparisons between samples

As demonstrated in antibody characterization studies, using genetic knockout controls is particularly important for confirming specificity, and this principle applies strongly to ChIP experiments where non-specific binding can lead to false positives .

Why might my YOR376W antibody show inconsistent results between experiments, and how can I address this?

Inconsistent results with YOR376W antibody may stem from several factors that can be systematically addressed:

• Antibody quality and stability issues:

  • Lot-to-lot variability: Request certificate of analysis for each lot and compare with previous lots

  • Antibody degradation: Aliquot antibodies to avoid freeze-thaw cycles and store at recommended temperature

  • Precipitation: Centrifuge before use and observe for visible precipitates

  • Solution: Consider switching to recombinant antibodies which have been shown to outperform both monoclonal and polyclonal antibodies in consistency tests

• Sample preparation variables:

  • Yeast growth phase differences: Standardize culture OD600 at harvest

  • Extraction buffer variations: Use consistent lysis protocol and buffer composition

  • Protein modification states: Consider phosphatase/deacetylase inhibitors if post-translational modifications affect epitope recognition

  • Solution: Develop a detailed SOP for sample preparation with precise timing and conditions

• Technical variations:

  • Incubation time/temperature fluctuations: Use temperature-controlled environments and timers

  • Washing stringency differences: Standardize wash volumes, duration, and number

  • Buffer preparation inconsistencies: Prepare larger stocks of buffers to reduce batch effects

  • Solution: Implement automated systems where possible to reduce operator variability

• Detection system variables:

  • Substrate depletion: Ensure excess substrate for enzymatic detection methods

  • Exposure time differences: Standardize image acquisition parameters

  • Equipment variability: Calibrate instruments regularly

  • Solution: Use fluorescence-based detection which provides better linearity and reproducibility

• Reference standards:

  • Implement internal controls in each experiment

  • Include standard curves where appropriate

  • Use pooled reference samples across experiments for normalization

  • Solution: Adopt the consensus protocols developed through efforts like YCharOS for standardized approaches

Creating detailed protocols with defined acceptance criteria for controls can help identify the source of variability and improve consistency across experiments.

How can I determine if observed YOR376W antibody signals represent true protein expression or artifacts?

Distinguishing genuine YOR376W signals from artifacts requires a systematic approach with multiple validation strategies:

• Genetic validation approaches:

  • Compare wild-type signal with YOR376W knockout strains (gold standard negative control)

  • Test dose-dependency with overexpression strains

  • Use inducible expression systems to observe signal correlation with induction

  • Examine multiple yeast strains to confirm consistent expression patterns

• Antibody validation strategies:

  • Test multiple antibodies against different YOR376W epitopes

  • Perform peptide competition assays where pre-incubation with immunizing peptide should abolish specific signal

  • Compare antibody results with tagged protein detection (e.g., GFP-YOR376W)

  • Validate with orthogonal methods (mass spectrometry, RNA expression)

• Signal characteristics assessment:

  • Evaluate signal-to-noise ratio across replicates

  • Assess molecular weight accuracy in Western blots

  • Check for expected subcellular localization pattern

  • Examine consistency of signal across multiple experimental conditions

• Artifact identification:

  • Test for cross-reactivity with closely related yeast proteins

  • Evaluate non-specific binding through isotype controls

  • Check for detection system artifacts (e.g., edge effects in immunofluorescence)

  • Assess sample preparation artifacts through multiple extraction methods

• Independent verification:

  • Consult antibody repositories like YCharOS for independent validation data

  • Refer to published literature using the same antibody

  • Consider targeted mass spectrometry for antibody-independent verification

  • Implement CRISPR-based tagging for endogenous protein detection

Studies have shown that about 50% of commercial antibodies fail to meet basic standards for characterization , highlighting the importance of rigorous validation. The YCharOS initiative has demonstrated that searching by target protein in antibody repositories can help identify which antibodies have been independently validated as specific for their targets .

What strategies can address weak or absent YOR376W antibody signal in Western blots despite confirmed gene expression?

When faced with weak or absent YOR376W antibody signal despite confirmed gene expression, consider these sequential troubleshooting approaches:

• Protein extraction optimization:

  • Test harsher extraction methods for yeast cells (e.g., TCA precipitation, glass bead lysis)

  • Evaluate different lysis buffers to improve solubilization

  • Add specific detergents appropriate for membrane proteins if YOR376W is membrane-associated

  • Incorporate protease inhibitors to prevent degradation

  • Check extraction efficiency by comparing different fractions (soluble vs. insoluble)

• Epitope accessibility issues:

  • Test both reducing and non-reducing conditions

  • Vary denaturation conditions (boiling time, temperature)

  • Try different blocking agents (BSA vs. milk)

  • Consider native vs. denaturing conditions if conformation affects epitope recognition

  • Test membrane stripping and reprobing with alternative antibodies

• Signal enhancement strategies:

  • Increase protein loading (up to 50-100 μg per lane)

  • Extend primary antibody incubation (overnight at 4°C)

  • Try signal amplification systems (biotin-streptavidin, tyramide)

  • Use more sensitive detection substrates

  • Optimize transfer conditions (time, buffer composition, membrane type)

• Antibody optimization:

  • Test different antibody concentrations in a broad range

  • Try alternative antibodies targeting different epitopes

  • Consider antibody purification if using serum or ascites

  • Evaluate freshly prepared antibody dilutions

  • Test antibodies from different suppliers or production methods

• Methodological alternatives:

  • Consider immunoprecipitation followed by Western blot for enrichment

  • Try dot blots to determine if transfer is the issue

  • Use enriched subcellular fractions if expression is compartmentalized

  • Implement targeted mass spectrometry as an antibody-independent approach

  • Generate epitope-tagged constructs as an alternative detection strategy

Research has shown that recombinant antibodies consistently outperform both monoclonal and polyclonal antibodies in various assays , suggesting that switching to a recombinant YOR376W antibody might resolve detection issues. Additionally, consulting antibody repositories and search engines can help identify antibodies with validated performance in specific applications .

How can I integrate YOR376W antibody-based techniques with other -omics approaches for comprehensive protein function analysis?

Integrating YOR376W antibody-based techniques with other -omics approaches creates a powerful multi-dimensional analysis framework:

• Antibody-based proteomics integration:

  • Combine immunoprecipitation with mass spectrometry (IP-MS) to identify YOR376W interaction partners

  • Correlate Western blot quantification with global proteomics data

  • Use ChIP-seq with YOR376W antibody alongside RNA-seq to connect DNA binding with transcriptional outcomes

  • Implement proximity labeling (BioID, APEX) with YOR376W as bait, followed by mass spectrometry

• Functional genomics correlation:

  • Compare YOR376W protein levels (antibody-detected) with phenotypic screens of genetic perturbations

  • Correlate antibody-detected localization with high-content screening data

  • Integrate with genome-wide CRISPR screens to identify genetic interactions

  • Validate computational predictions of function using antibody-based assays

• Multi-omics data integration approaches:

  • Develop computational frameworks to integrate antibody-based protein data with transcriptomics and metabolomics

  • Implement time-course studies capturing dynamic changes across multiple -omics layers

  • Use machine learning approaches to identify patterns across datasets

  • Create network models incorporating protein-protein, protein-DNA, and metabolic interactions

• Technical integration strategies:

  • Adopt standardized sample processing compatible with multiple downstream analyses

  • Implement internal standards across platforms for cross-methodology normalization

  • Develop multiplexed assays combining antibody detection with other markers

  • Create integrated workflows minimizing sample splitting to reduce variability

• Validation and quality control:

  • Use orthogonal methods to validate findings across platforms

  • Implement proper controls for each methodology

  • Ensure antibody specificity as demonstrated in studies like those from YCharOS

  • Consider recombinant antibodies which have shown superior performance in multiple assays

The YCharOS initiative and similar efforts have demonstrated the importance of rigorous antibody validation when integrating multiple data types, as non-specific antibodies can lead to misleading correlations between datasets . Standardized approaches for antibody-based methods provide a solid foundation for multi-omics integration.

What are the considerations for developing and validating custom YOR376W antibodies for specialized applications?

Developing custom YOR376W antibodies requires strategic planning and comprehensive validation:

• Antigen design considerations:

  • Select unique, accessible regions with high antigenicity predictions

  • Consider multiple epitopes (N-terminal, C-terminal, internal regions)

  • Evaluate sequence conservation if cross-species reactivity is desired

  • Assess potential post-translational modifications that might affect epitope recognition

  • Design peptides that avoid regions with potential cross-reactivity

• Antibody format selection:

  • Compare advantages of polyclonal, monoclonal, and recombinant approaches

  • Consider recombinant antibodies which have shown superior performance across applications

  • Evaluate different isotypes based on application needs

  • Assess fragment-based formats (Fab, scFv) for specific applications

  • Consider fusion proteins (e.g., nanobody formats) for specialized applications

• Production approaches:

  • Evaluate traditional animal immunization versus phage display or synthetic libraries

  • Consider humanized antibodies if translational applications are anticipated

  • Implement rigorous purification protocols to ensure quality

  • Document all production parameters for reproducibility

  • Create renewable sources (hybridomas, recombinant expression) for long-term availability

• Comprehensive validation strategy:

  • Test against recombinant protein, wild-type, and knockout samples

  • Evaluate performance in multiple applications (Western blot, IP, IF, ChIP)

  • Assess cross-reactivity with related proteins

  • Document epitope mapping results

  • Perform application-specific validation according to established consensus protocols

• Characterization documentation:

  • Create detailed validation reports following standardized formats

  • Share validation data in public repositories

  • Include controls and applications tested

  • Document batch variation and stability data

  • Provide application-specific protocols and recommendations

Recent studies have highlighted that about 50% of commercial antibodies fail to meet basic standards for characterization , emphasizing the importance of rigorous validation. The approach developed by YCharOS using knockout cell lines should be implemented as the gold standard for validation, particularly for establishing specificity .